Latest Breaking News On - Jeff coller - Page 1 : comparemela.com

Johns Hopkins to establish new RNA innovation center in collaboration with TriLink BioTechnologies

The center, anchored in the Institute for NanoBioTechnology, will speed the cycle of RNA innovation in pursuit of advanced therapies

Sashank-reddy
Jeff-coller
Paul-nkansah
Hai-quan-mao
Ed-schlesinger
Johns-hopkins
Maravai-lifesciences
Whiting-school-of-engineering
Johns-hopkins-technology-ventures
Johns-hopkins-university
Whiting-school
Institute-for-nanobiotechnology

TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center

TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Jeff-coller
Johns-hopkins
Maravai-lifesciences
Ed-schlesinger
Maravaitm-lifesciences
Innovation-center
Nasdaq
Product-service
Whiting-school-of-engineering
Johns-hopkins-whiting-school-of-engineering
Johns-hopkins-university
Institute-of-nanobiotechnology

Harnessing mRNA Metabolism for the Development of Precision Therapeutics

Harnessing mRNA Metabolism for the Development of Precision Therapeutics
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

Jeff-coller
Broadcast-date

Hope for haploinsufficiency diseases | Popular Science

Genetic conditions like Dravet syndrome are hard to tackle with traditional gene therapy. But new approaches are in the works.

Massachusetts
United-states
Toronto
Ontario
Canada
Montreal
Quebec
Cold-spring-harbor-laboratory
New-york
Spain
Bedford
Cambridge

Tevard Biosciences announces collaboration with Vertex to develop novel tRNA-based therapies for Duchenne muscular dystrophy

/PRNewswire/ Tevard Biosciences, Inc., the pioneer of tRNA-based therapies for severe genetic diseases, today announced a four-year global research.

Cambridge
Cambridgeshire
United-kingdom
Jeff-coller
Rebecca-zacks
Mike-cooke
Harvey-lodish
Tevard-biosciences
Warren-lammert
Daniel-fischer
Department-of-molecular-biology
Tevard-biosciences-inc